Downloads: 3 | Views: 206 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Ophthalmology | India | Volume 12 Issue 5, May 2023 | Popularity: 4.9 / 10

Rate This Article!      

Our Experience with Retrobulbar Amphotericin-B in Patients of Rhino-Orbital-Cerebral Mucormycosis (ROCM) at GMERS Gotri

Dr. Kamlesh Gendalbhai Damor, Dr. Ruju K. Upadhyaya, Dr. Hemali A. Patel, Dr. Ashwini Sapre

Abstract: Purpose: To evaluate ocular features in Rhino-Orbital-Cerebral Mucormycosis (ROCM) and to study outcome of retrobulbar injection Amphotericin-b in the patients of ROCM following COVID-19. Methods: 118 confirmed cases of ROCM following COVID-19 were analyzed retrospectively. Results: Out of 118 patients, 74 patients had disease in the nose and paranasal sinuses (PNS), 37 showed orbital involvement as well and 7 patients had severe disease involving the brain also. Out of 118 patients, 17 patients were given Retrobulbar Amphotericin-B injection of which 13 recovered well.5 orbital exenterations were done, out of which one patient survived. Conclusion: Retrobulbar Amphotericin ?B injection serves important role in preventing spread of fungus to the brain and improving mortality.

Keywords: COVID-19, Rhino-Orbital-Cerebral Mucormycosis, Retrobulbar Amphotericin-B, exenteration

Edition: Volume 12 Issue 5, May 2023

Pages: 727 - 729

DOI: https://www.doi.org/10.21275/SR23509173701

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article

Similar Articles